DE69121999D1 - Verfahren und Produkt für die Behandlung von Magenkrankheiten - Google Patents

Verfahren und Produkt für die Behandlung von Magenkrankheiten

Info

Publication number
DE69121999D1
DE69121999D1 DE69121999T DE69121999T DE69121999D1 DE 69121999 D1 DE69121999 D1 DE 69121999D1 DE 69121999 T DE69121999 T DE 69121999T DE 69121999 T DE69121999 T DE 69121999T DE 69121999 D1 DE69121999 D1 DE 69121999D1
Authority
DE
Germany
Prior art keywords
treatment
product
gastric diseases
gastric
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69121999T
Other languages
English (en)
Other versions
DE69121999T2 (de
Inventor
Christopher Thurman Cordle
Joseph Paul Schaller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24235049&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69121999(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of DE69121999D1 publication Critical patent/DE69121999D1/de
Application granted granted Critical
Publication of DE69121999T2 publication Critical patent/DE69121999T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/121—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Helicobacter (Campylobacter) (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DE69121999T 1990-07-30 1991-07-11 Verfahren und Produkt für die Behandlung von Magenkrankheiten Expired - Lifetime DE69121999T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55979390A 1990-07-30 1990-07-30

Publications (2)

Publication Number Publication Date
DE69121999D1 true DE69121999D1 (de) 1996-10-17
DE69121999T2 DE69121999T2 (de) 1997-04-10

Family

ID=24235049

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69121999T Expired - Lifetime DE69121999T2 (de) 1990-07-30 1991-07-11 Verfahren und Produkt für die Behandlung von Magenkrankheiten

Country Status (8)

Country Link
EP (1) EP0469359B1 (de)
JP (1) JP2968095B2 (de)
AU (1) AU640495B2 (de)
CA (1) CA2047843C (de)
DE (1) DE69121999T2 (de)
ES (1) ES2094170T3 (de)
IE (1) IE76730B1 (de)
NZ (1) NZ238674A (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780028A (en) * 1993-09-20 1998-07-14 Anadis Ltd. Method of obtaining immunoglobulins from colostrum and their use in pharmaceutical composition
DE19548221C1 (de) * 1995-12-22 1997-05-15 Biotest Pharma Gmbh Orale Anwendung von Immunglobulin-Präparationen zur Behandlung und Prophylaxe chronischer Schmerzzustände
JP3430853B2 (ja) 1997-04-11 2003-07-28 株式会社ゲン・コーポレーション 胃炎、胃潰瘍および十二指腸潰瘍の予防剤並びに治療剤
CA2291487A1 (en) * 1997-05-29 1998-12-03 New Zealand Pastoral Agriculture Research Institute Limited Processes for production of immunoglobulin a in milk
CN1063091C (zh) * 1997-09-01 2001-03-14 黄河 一种功能食品免疫牛奶
JP4763149B2 (ja) * 2001-05-10 2011-08-31 わかもと製薬株式会社 ヘリコバクター・ピロリへの感染を判定する検査方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH627079A5 (en) * 1977-04-15 1981-12-31 Nestle Sa Process for preparing a protein concentrate containing immunological factors of milk origin
FR2637612B1 (fr) * 1988-10-06 1993-09-10 Pasteur Institut Sequences de nucleotides codant pour une proteine a activite ureasique

Also Published As

Publication number Publication date
AU640495B2 (en) 1993-08-26
NZ238674A (en) 1993-07-27
ES2094170T3 (es) 1997-01-16
CA2047843C (en) 2001-10-30
IE912159A1 (en) 1992-02-12
AU8020791A (en) 1992-02-06
EP0469359B1 (de) 1996-09-11
CA2047843A1 (en) 1992-01-31
JP2968095B2 (ja) 1999-10-25
EP0469359A3 (en) 1992-04-08
JPH04330099A (ja) 1992-11-18
EP0469359A2 (de) 1992-02-05
IE76730B1 (en) 1997-11-05
DE69121999T2 (de) 1997-04-10

Similar Documents

Publication Publication Date Title
DE3776637D1 (de) Verfahren und vorrichtung fuer die behandlung von produktteilchen.
DE69100303T2 (de) Verfahren für die gleichzeitige Behandlung von zwei gefährlichen Chargen.
ATA242288A (de) Dosierungsform für die behandlung kardiovaskulärer erkrankungen
DE3856398T2 (de) Verfahren zur Behandlung von Gleitkörpern
DE69312631D1 (de) Material für die behandlung von tierexkrementen und verfahrung zu dessen herstellung
ATE252901T1 (de) Arzneimittel zur behandlung von entzündlichen herzkrankheiten
DE69222258T2 (de) Einrichtung und Verfahren für die Behandlung von Aussenwänden
ATE204704T1 (de) Verwendung von bcl-2 zur herstellung von arzneimitteln zur therapeutischen behandlung und verhinderung von krankheiten
DE69317632T2 (de) Verfahren zur Behandlung von Ozonschicht dezimierenden Substanzen
DE69109583T2 (de) Verfahren zur Behandlung von entzündlichen Darmerkrankungen.
DE69427774D1 (de) Kontinuierliches verfahren zur behandlung von nahrungsmitteln
DE69011951T2 (de) Verfahren zur Behandlung und Herstellung von Material.
DE69429160T2 (de) Behandlung von textilprodukt
DE69532066D1 (de) Arzneimittel zur Behandlung von Restenosis und Gefässsklerose
DE69108158T2 (de) Verfahren zum kontinuierlichen Herstellen von Trägern für gebündelte Schaltungen und so hergestelltes Erzeugnis.
DE69031122D1 (de) Verfahren und vorrichtung für die behandlung und verhinderung von rückgrathaltungsmängeln
DE549492T1 (de) Verfahren zur Behandlung von Abfallverbrennungsrückständen und daraus herhaltene Produkt.
DE69031657T2 (de) Verfahren und erzeugnisse für die asbestbehandlung
DE69225754T2 (de) Verfahren zur Behandlung von wasserunlöslichen Superabsorbensmaterialien
DE69121999D1 (de) Verfahren und Produkt für die Behandlung von Magenkrankheiten
DE69512977T2 (de) Material für die Behandlung von Tierexkrementen und Verfahren zu dessen Herstellung
DE69016083D1 (de) Vorrichtung und Verfahren für die gleichmässige Behandlung von grossen Mengen von kleinen Teilen.
DE69535154D1 (de) Verfahren zur Behandlung von Textilmaterialien
DE59007538D1 (de) Verfahren zur Behandlung von gewalzten Bändern.
DE59104484D1 (de) Verfahren und Vorrichtung zur Behandlung von feuchten Gas-Staub-Gemischen.

Legal Events

Date Code Title Description
8363 Opposition against the patent
8365 Fully valid after opposition proceedings